In the past 50 years, only one new tuberculosis drug has come on to the market, yet many more active substances are urgently needed.
Current treatments increasingly fail due to multidrug-resistant pathogens. ETH researchers have now applied to patent a novel approach for developing new tuberculosis drugs.
Consumption was one of the worst known diseases of the 18th century. Thanks to medical advances, the number of deaths from this lung disease – which is today known as tuberculosis – has declined significantly. Efforts to eradicate the disease in the 1950s and 1960s resulted in a wide range of new drugs entering the market.
And yet 1.4 million people still continue to die each year from tuberculosis. Multidrug-resistant strains of the disease-causing pathogen are especially dangerous because they can no longer be treated with today’s drugs (see box). “In the past 50 years, only one new tuberculosis drug has come on to the market, and that was in 2012,” says Karl-Heinz Altmann, Professor of Pharmaceutical Biology at ETH Zurich. New active substances that are able to kill multidrug-resistant strains of the disease are therefore urgently needed. Altmann and his team have now laid the foundation for new tuberculosis drugs, and they were inspired by a bacteria-derived antibiotic called pyridomycin.
Learn more . . .
The Latest on: Tuberculosis drugs
[google_news title=”” keyword=”Tuberculosis drugs” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Tuberculosis drugs
- A Looming Crisis - Kalungu District Grapples With Drug Shortageson April 27, 2024 at 5:04 am
A dark cloud hangs over Kalungu District, Uganda. Since January 2024, government health facilities have faced a critical shortage of essential drugs, leaving patients in a desperate scramble for ...
- Experts develop immune-enhancing therapies to target tuberculosison April 26, 2024 at 3:10 pm
Experts are working on novel immune-enhancing therapies called host-directed therapies to use the body's own immune system to target tuberculosis, with hopes that they could tackle even the ...
- TB Clinical Trials: An UnPrecedented â ¬34 Million Price Tag in Drug Development [press release]on April 26, 2024 at 11:10 am
At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders (MSF) presented the costs of its landmark TB-PRACTECAL clinical trial that helped identify a ...
- Experts developing immune-enhancing therapies to target tuberculosison April 25, 2024 at 5:00 pm
Some immune-enhancing therapies already exist, and their use could be investigated while other immunomodulatory drugs specific to different sub-groups of TB disease are being developed Experts are ...
- Drug-resistant tuberculosis responds rapidly to bedaquiline-based second-line therapy, claims studyon April 25, 2024 at 8:31 am
Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking ...
- Centre alerted about scarcity of TB drugson April 22, 2024 at 4:27 pm
Bhubaneswar: Odisha on Monday raised alarm about short supply of anti-tuberculosis (TB) medicines which may severely affect the drive against eliminat.
- TB drugs shortage hits Zim hospitalson April 21, 2024 at 8:01 pm
In Zimbabwe, 18 200 people fell ill with TB in 2022, with 242 cases of DR-TB being notified to the TB control programme. A survey by Standard People showed that drugs such as Rifampicin, Isoniazid, ...
- We neglect ancient killers like tuberculosis at our perilon April 18, 2024 at 12:00 am
Treating TB might not be big business, but it still kills more than one million people every year — more than any other infectious disease on earth.
- Absence of full drug-susceptibility data for TB patients can result in amplifying resistance: studyon April 16, 2024 at 7:48 pm
Study by HaystackAnalytics & Dr. D.Y. Patil Medical College reveals high prevalence of pre-XDR-TB in MDR-TB cases in India.
- Centre needs to solve TB drug shortage soonon April 16, 2024 at 12:06 pm
India’s ambitious goal of eliminating tuberculosis in the country by 2025 is in serious jeopardy. The reason? The repeated instances of a serious shortage of drugs that are essential to treat the ...
via Bing News